Literature DB >> 30458624

Ideal Cardiovascular Health Status and Risk of Cardiovascular Disease or All-Cause Mortality in Chinese Middle-Aged Population.

Ying Dong1, Guang Hao2, Zengwu Wang1, Xin Wang1, Zuo Chen1, Linfeng Zhang1.   

Abstract

We estimated the prevalence of ideal cardiovascular health (CVH), and its relationship with cardiovascular disease (CVD) and all-cause mortality in a Chinese population. A cross-sectional survey of CVD risk factors was conducted among Chinese participants aged 35 to 64 years in 2009 to 2010. In 2017, 8965 participants completed follow-up assessments in which CVD and all-cause mortality were collected; 8754 participants were eligible for analysis. The percentage of meeting all 7 ideal CVH metrics was 0.10%. During a median follow-up of 6.3 years, the incidence of CVD and all-cause mortality were 6.02% and 4.85% per 1000 person-year in participants with 0 to 1 ideal CVH metrics, 3.33% and 3.57% in those with 2 to 5, 0.40% and 0.79% in those with 6 to 7, respectively. After adjusting for covariates, the risk of CVD was significantly lower in participants with 2 to 5 (hazard ratio [HR]: 0.67, 95% confidence interval [CI]: 0.45-0.98) and 6 to 7 (HR: 0.12, 95%CI: 0.02-0.87) ideal CVH metrics compared to those with 0 to 1 ideal CVH metrics. The risk of all-cause mortality was decreased as ideal CVH metrics increased (HR: 0.78, 95%CI: 0.70-0.88). A greater number of ideal CVH metrics was associated with a lower risk of CVD and all-cause mortality, but the prevalence of all 7 ideal CVH metrics was low in a Chinese population.

Entities:  

Keywords:  Chinese; all-cause mortality; cardiovascular disease; cohort study; ideal cardiovascular health

Mesh:

Substances:

Year:  2018        PMID: 30458624     DOI: 10.1177/0003319718813448

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  7 in total

1.  Scientometric Analysis of The Relationship between a Built Environment and Cardiovascular Disease.

Authors:  Zhonghui Zheng; Ping Zhang; Fangzheng Yuan; Yunque Bo
Journal:  Int J Environ Res Public Health       Date:  2022-05-05       Impact factor: 4.614

2.  Association of Night Sleep Duration and Ideal Cardiovascular Health in Rural China: The Henan Rural Cohort Study.

Authors:  Xueyan Wu; Xiaotian Liu; Wei Liao; Ning Kang; Shengxiang Sang; Tanko Abdulai; Zhihan Zhai; Chongjian Wang; Xiaoqiong Wang; Yuqian Li
Journal:  Front Public Health       Date:  2021-01-11

3.  Association between the Mediterranean lifestyle, metabolic syndrome and mortality: a whole-country cohort in Spain.

Authors:  Mercedes Sotos-Prieto; Rosario Ortolá; Miguel Ruiz-Canela; Esther Garcia-Esquinas; David Martínez-Gómez; Esther Lopez-Garcia; Miguel Ángel Martínez-González; Fernando Rodriguez-Artalejo
Journal:  Cardiovasc Diabetol       Date:  2021-01-05       Impact factor: 9.951

4.  Associations of behaviors, biological phenotypes and cardiovascular health with risks of stroke and stroke subtypes: A prospective cohort study.

Authors:  Zhi Cao; Shu Li; Hongxi Yang; Chenjie Xu; Yuan Zhang; Xueli Yang; Tao Yan; Tong Liu; Yaogang Wang
Journal:  EClinicalMedicine       Date:  2021-03-18

5.  Changes in Cardiovascular Health Status and Risk of Sudden Cardiac Death in Older Adults.

Authors:  Min Kim; Pil Sung Yang; Hee Tae Yu; Tae Hoon Kim; Eunsun Jang; Jae Sun Uhm; Hui Nam Pak; Moon Hyoung Lee; Boyoung Joung
Journal:  Yonsei Med J       Date:  2021-04       Impact factor: 2.759

6.  Ideal cardiovascular health status and risk of cardiovascular disease and all-cause mortality: over a decade of follow-up in the Tehran lipid and glucose study.

Authors:  Farzad Hadaegh; Somayeh Hosseinpour-Niazi; Niloofar Deravi; Mitra Hasheminia; Nazanin Moslehi; Hossein Toreyhi; Fereidoun Azizi
Journal:  Front Cardiovasc Med       Date:  2022-08-04

7.  Social determinants status and hypertension: A Nationwide Cross-sectional Study in China.

Authors:  Congyi Zheng; Zengwu Wang; Xin Wang; Zuo Chen; Linfeng Zhang; Yuting Kang; Ying Yang; Linlin Jiang; Runlin Gao
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-03       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.